L Segall, I Nistor, A Covic - BioMed research international, 2014 - Wiley Online Library
Introduction. Heart failure (HF) is highly prevalent in patients with chronic kidney disease (CKD) and end‐stage renal disease (ESRD) and is strongly associated with mortality in …
Background—The prevalence, prognostic import, and impact of renal insufficiency on the benefits of ACE inhibitors and β-blockers in community-dwelling patients with heart failure …
Platelets, Fourth Edition, integrates the entire field of platelet biology, pathophysiology, and clinical medicine with contributions from 142 world experts from 18 countries. This award …
Background: Patients with end-stage renal disease are known to have decreased survival after myocardial infarction, but the association of less severe renal dysfunction with survival …
S Weitzen, KL Lapane, AY Toledano… - … and drug safety, 2004 - Wiley Online Library
Purpose To document which established criteria for logistic regression modeling researchers consider when using propensity scores in observational studies. Methods We …
Objectives: This study was designed to examine the use of cardiovascular medications and outcomes in patients with heart failure (HF) and renal dysfunction. Background: Renal …
MR Loizzo, A Said, R Tundis, K Rashed… - … Journal Devoted to …, 2007 - Wiley Online Library
In our screening program for antihypertensive properties of plants, the leaves of Ailanthus excelsa (Roxb), a plant used in Egyptian traditional medicine, were analysed …
The development of heart failure and/or left ventricular systolic dysfunction (LVSD) in the setting of acute myocardial infarction (AMI) results in significant risk far above that of AMI …
MG Shlipak - Annals of internal medicine, 2003 - acpjournals.org
Clinical trials have demonstrated that angiotensin-converting enzyme (ACE) inhibitors,- blockers, and spironolactone improve survival in patients with heart failure. Because …